PL2435026T3 - Leczenie zrostu tkanek - Google Patents

Leczenie zrostu tkanek

Info

Publication number
PL2435026T3
PL2435026T3 PL10721165T PL10721165T PL2435026T3 PL 2435026 T3 PL2435026 T3 PL 2435026T3 PL 10721165 T PL10721165 T PL 10721165T PL 10721165 T PL10721165 T PL 10721165T PL 2435026 T3 PL2435026 T3 PL 2435026T3
Authority
PL
Poland
Prior art keywords
treatment
tissue adhesion
adhesion
tissue
Prior art date
Application number
PL10721165T
Other languages
English (en)
Inventor
Jacob Koopman
Original Assignee
Mallinckrodt Pharma Ip Trading D.A.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Pharma Ip Trading D.A.C. filed Critical Mallinckrodt Pharma Ip Trading D.A.C.
Publication of PL2435026T3 publication Critical patent/PL2435026T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL10721165T 2009-05-28 2010-05-28 Leczenie zrostu tkanek PL2435026T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0909136.4A GB0909136D0 (en) 2009-05-28 2009-05-28 Dry powder composition
PCT/EP2010/057478 WO2010136589A1 (en) 2009-05-28 2010-05-28 Treatment of tissue adhesion
EP10721165.8A EP2435026B1 (en) 2009-05-28 2010-05-28 Treatment of tissue adhesion

Publications (1)

Publication Number Publication Date
PL2435026T3 true PL2435026T3 (pl) 2018-05-30

Family

ID=40863069

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10721165T PL2435026T3 (pl) 2009-05-28 2010-05-28 Leczenie zrostu tkanek

Country Status (10)

Country Link
US (1) US9089584B2 (pl)
EP (2) EP3205336A1 (pl)
JP (1) JP2012528131A (pl)
CN (1) CN102448442A (pl)
AU (1) AU2010252930B2 (pl)
CA (1) CA2761904C (pl)
ES (1) ES2626118T3 (pl)
GB (1) GB0909136D0 (pl)
PL (1) PL2435026T3 (pl)
WO (1) WO2010136589A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010252929B2 (en) * 2009-05-28 2015-08-27 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
EP2521538B1 (en) * 2010-01-08 2018-10-24 Mallinckrodt Pharma IP Trading D.A.C. Dry powder fibrin sealant
US8535590B2 (en) * 2011-01-12 2013-09-17 Cook Medical Technologies Llc Spray system and method of making phase separated polymer membrane structures
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
AU2014224594B2 (en) * 2013-03-07 2018-05-10 Mallinckrodt Pharma Ip Trading D.A.C. Powder formulation comprising thrombin and fibrinogen
US20220125736A1 (en) * 2019-02-06 2022-04-28 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting post-surgical adhesions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2948254B2 (ja) 1990-03-06 1999-09-13 ユニチカ株式会社 癒着防止材
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
JPH10506406A (ja) 1994-09-29 1998-06-23 アンダリス、リミテッド 治療用ビヒクルとしての噴霧乾燥させた微細粒子
JPH08157491A (ja) 1994-11-30 1996-06-18 Hayashibara Biochem Lab Inc トレハロース誘導体の製造方法
PT796090E (pt) 1994-12-16 2003-07-31 Elan Drug Delivery Ltd Microparticulas reticuladas e sua utilizacao como veiculos terapeuticos
US5702715A (en) 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
AU702955B2 (en) * 1996-05-17 1999-03-11 Quadrant Healthcare (Uk) Limited Microparticles and their use in wound therapy
WO1999042146A1 (en) * 1998-02-20 1999-08-26 Quadrant Healthcare (Uk) Limited Products comprising fibrinogen for use in therapy
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
DE19849589C1 (de) * 1998-10-27 2000-06-15 Glatt Process Technology Gmbh Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung
DE10025001A1 (de) 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
CN1364889A (zh) 2001-01-10 2002-08-21 上海博德基因开发有限公司 一种新的多肽——人周期蛋白依赖激酶16.82 和编码这种多肽的多核苷酸
CN1151253C (zh) * 2001-01-10 2004-05-26 中国科学院微生物研究所 海藻糖基水解酶及其制备和用途
DE60227691D1 (de) 2001-11-01 2008-08-28 Nektar Therapeutics Sprühtrocknungsverfahren
US20050118156A1 (en) 2001-12-04 2005-06-02 Woolverton Christopher J. Storage-stable fibrin sealant
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
AU2003282356A1 (en) 2002-11-20 2004-06-15 Bar-Ilan University Biological glue based on thrombin-conjugated nanoparticles
CN1454667A (zh) 2003-05-07 2003-11-12 徐振彪 使用方便的纤维蛋白封闭剂
CN1835723B (zh) * 2003-06-16 2011-06-22 洛马林达大学医学中心 可展开的多功能止血剂
WO2005021011A1 (en) 2003-08-28 2005-03-10 Altana Pharma Ag Use of surfactant preparations for the treatment of surgical adhesions
BRPI0508939A (pt) 2004-03-17 2007-08-14 Genzyme Corp pulverização antiadesão
CA2574773A1 (en) 2004-07-22 2006-02-02 Allan D. Pronovost Compositions and methods for treating excessive bleeding
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
JP5109030B2 (ja) * 2005-07-25 2012-12-26 茂 木下 シート状組成物
US8277837B2 (en) * 2006-01-11 2012-10-02 Entegrion, Inc. Hemostatic textile
DE602007011920D1 (de) 2006-05-26 2011-02-24 Baxter Healthcare Sa Injizierbarer füllstoff für knochenhohlräume
WO2008019129A2 (en) 2006-08-04 2008-02-14 Stb Lifesaving Technologies, Inc. Solid dressing for treating wounded tissue
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2010002435A2 (en) 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
US9827205B2 (en) 2008-12-12 2017-11-28 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
AU2010252929B2 (en) 2009-05-28 2015-08-27 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant

Also Published As

Publication number Publication date
CA2761904C (en) 2018-12-11
EP3205336A1 (en) 2017-08-16
US20120064165A1 (en) 2012-03-15
US9089584B2 (en) 2015-07-28
ES2626118T3 (es) 2017-07-24
AU2010252930B2 (en) 2015-07-02
WO2010136589A1 (en) 2010-12-02
CA2761904A1 (en) 2010-12-02
JP2012528131A (ja) 2012-11-12
CN102448442A (zh) 2012-05-09
AU2010252930A1 (en) 2011-12-08
EP2435026B1 (en) 2017-04-26
GB0909136D0 (en) 2009-07-01
EP2435026A1 (en) 2012-04-04

Similar Documents

Publication Publication Date Title
EP2629736A4 (en) FABRIC TREATMENT
EP2393914A4 (en) LUNG TISSUE ENGINEERING
IL208354A0 (en) Methods of treatment
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
HK1169804A1 (zh) 治療疼痛的方法
ZA201106730B (en) Methods of treatment using combination therapy
GB0915515D0 (en) Treatment of vasculoproliferative conditions
IL206491A0 (en) Treatment of produce
GB0908193D0 (en) Treatment of disease state
IL214133A0 (en) Skin treatment
GB0902040D0 (en) Composition for treatment of skin
PL2435026T3 (pl) Leczenie zrostu tkanek
ZA201107948B (en) Treatment of water
SG10201408187XA (en) Treatment of Bone Fracture
GB0908101D0 (en) Treatment of stress
EP2403507A4 (en) TREATMENT OF INFECTIONS
WO2011047309A9 (en) Treatment of ischemic tissue
GB0806047D0 (en) Treatment of heart failure
HK1178057A1 (zh) 骨質疏鬆的治療
EP2440238A4 (en) Methods of Treatment
ZA201005770B (en) The treatment of damaged skin
TWM400861U (en) Structure of treating tissue adhesion
GB0904073D0 (en) Treatment of influenza
GB0908666D0 (en) Treatment of proteostatic disease
AU2009902633A0 (en) Methods of treatment